VANCOUVER, BC, May 17, 2022
/CNW/ - Franchise Global Health Inc. ("Franchise Global" or
the "Company") (TSXV: FGH) (FRA: WV4A) announces the
appointment of Zeifmans LLP, Chartered Professional Accountants
("Zeifmans LLP"), as its new auditor effective as of
May 17, 2022.
Zeifmans LLP replaces RSM Canada LLP, Chartered Professional
Accountants as the Company's auditor. The board of directors and
management of the Company would like to thank RSM Canada LLP for
their excellent services. The change in auditor has been approved
by the Company's audit committee and board of directors.
There were no modified opinions in RSM Canada LLP's reports in
connection with the audits of the Company's two most recently
completed fiscal years ended December 31,
2021 and 2020, and there were no "reportable
events" (including "disagreements", "unresolved issues" or
"consultations" (in each case, as defined under applicable Canadian
securities laws).
The Company has filed the required notice regarding the change
of auditor as well as the required letters from each of RSM Canada
LLP and Zeifmans LLP under the Company's SEDAR profile at
www.sedar.com.
About Franchise Global
Franchise Global, through its subsidiaries, is a multi-national
operator in the medical cannabis and pharmaceutical industries,
with principal operations in Germany and with operations, assets, strategic
partnerships and investments internationally. Franchise Global's
business objective is to develop a fully‑integrated, leading
European medical cannabis business, with the goal of providing
high-quality pharmaceutical grade medical cannabis to distribution
partners and, ultimately, to patients, at competitive prices.
For more information please visit
www.franchiseglobalhealth.com.
Neither the TSX Venture Exchange nor its Market Regulator (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release.
SOURCE Franchise Global Health Inc.